. These systems often deliver multiple proteins with a variety of biochemical activities that, in a coordinated manner, modulate complex host cell processes, including cytoskeletal dynamics, membrane trafficking, transcription, cell cycle progression, signal transduction and protein ubiquitylation [3] [4] [5] . There has been significant progress in understanding the biochemical activities of many bacterial effectors, but how these diverse activities are ultimately coordinated after the effectors have been delivered into the eukaryotic host cell is less well understood. A growing number of studies have revealed that to exert their functions in a spatially coordinated manner, effector proteins must be accurately targeted to their place of action. The precise targeting of bacterial effectors to specific subcellular compartments presumably has many benefits. As bacterial effectors are delivered in low concentrations, targeting to precise subcellular locations can increase the effective concentration of these proteins. Perhaps more importantly, the sub cellular targeting of effectors ensures the engagement of the correct targets for their various biochemical activities.
Eukaryotic cells are organized into discrete compartments that are most often membrane bound. Therefore, eukaryotic proteins destined for these locations have evolved specific sorting signals or targeting motifs that determine their final destination. These signals are often recognized by multiprotein machines that directly mediate protein transport or further modify the target proteins so that they can become transport competent. The compartmentalized organization of eukaryotic cells also presents a major challenge to the precise subcellular targeting of bacterial effectors, which are usually delivered directly into the cytosol of the target cell. However, bacterial effectors have evolved various strategies to reach their final destinations. These strategies often involve exploitation of the eukaryotic host cell machinery; some strategies require signal sequences embedded within the amino acid sequence of the effectors themselves, and other strategies entail post-translational modification of the effector before it is targeted to its final destination. Here, we discuss different examples of effector-targeting mechanisms (TABLE 1) . Instead of a comprehensive review of the literature, we focus on a few of the most wellcharacterized examples that illustrate the main themes which have been revealed as a result of studying the subcellular targeting of bacterial effectors.
Lipid rafts
Small (~70 nm width), dynamic microdomains of the plasma membrane that are enriched in cholesterol, and in sphingolipids and phospholipids with saturated acyl chains.
Caveolae
Specialized lipid raft regions of the plasma membrane that contain the protein caveolin and form flask-shaped, cholesterol-rich invaginations of the membrane.
E3 ligase
An enzyme that is required to attach the molecular tag ubiquitin to proteins, This tag modifies protein function or targets the protein for proteosomal degradation.
of lipid groups increases the hydrophobicity of proteins, thus facilitating their tethering to intracellular membranes and, as a result, affecting protein localization and function. Some proteins are exclusively modified by a single lipid group, whereas others are sequentially modified with different lipids, allowing for multiple layers of targeting information. Lipidation of proteins not only promotes their membrane association, but also directs their association with liquid-order domains of the membrane, such as lipid rafts and caveolae. The major forms of protein lipidation in eukaryotes are S-palmitoylation, N-myristoylation and prenylation.
S-palmitoylation. S-palmitoylation
has an important role in regulating protein stability and activity, as well as protein-protein interactions [6] [7] [8] . This modification is unique among lipid modifications in that it is generally reversible and can therefore affect protein function by dynamically controlling protein-protein interactions and/or the association of the protein with the membrane. S-palmitoylation is characterized by the addition of a saturated 16-carbon palmitic acid to a specific Cys residue in a protein through a thioester bond 8 (FIG. 1a) . Unlike other lipid modifications, S-palmitoylation has no clear amino acid sequence requirement other than the presence of a Cys residue. In eukaryotic cells, S-palmitoylation is catalysed by a family of 23 Asp-His-His-Cys (DHHC) motifcontaining proteins that have S-palmitoyltransferase activity 9 . DHHC proteins (also known as ZDHHC proteins) are polytopic membrane proteins that are found on a range of cellular membranes and have a conserved cytoplasmic-facing Cys-rich domain that includes the DHHC catalytic motif.
Salmonella enterica causes gastroenteritis and typhoid fever, a life-threatening systemic disease. A recent study has shown that host-mediated S-palmitoylation of an amino-terminal Cys residue of the Salmonella enterica T3SS effector SspH2 results in targeting of this effector to the host cell plasma membrane 10 (FIG. 1a) . On the basis of amino acid sequence similarity, many other potentially S-palmitoylated S. enterica T3SS effectors were identified in this study, including SseI. Both SspH2 and SseI are targeted to the plasma membrane in an S-palmitoylation-dependent manner. Screening the DHHC family identified a subset of enzymes able to catalyse the S-palmitoylation of SspH2 and SseI 10 . Two of these enzymes, DHHC3 and DHHC7, can S-palmitoylate SspH2 and SseI directly in vitro. DHHC3 and DHHC7 are phylogenetically related and have been shown to be active towards other N-terminally S-palmitoylated substrates. Although both SspH2 and SseI are stably S-palmitoylated, they are targeted to different domains of the plasma membrane of polarized cells 10 (FIG. 1a) .
This suggests that although S-palmitoylation is essential for plasma membrane localization, it is not sufficient to target these effectors to their final destination. SspH2 belongs to a family of bacterial effectors that possess a C-terminal NEL (new E3 ligase) domain and have been implicated in immune response modulation during infection 11, 12 . The C-terminal domain of SseI has amino acid sequence similarity with a family of bacterial deamidases 13 and has been reported to regulate cell migration 13, 14 , a function that requires SseI S-palmitoylation and plasma membrane targeting 10 . Thus, S. enterica has evolved to exploit host-mediated S-palmitoylation to target at least two distinct biochemical activities to their sites of action at the host cell plasma membrane. N-myristoylation. N-myristoylation results in the covalent attachment of 14-carbon myristic acid, via an amide bond, primarily to the α-amino group of an N-terminal Gly residue 15 (FIG. 1b) . This modification is catalysed by an N-myristoyltransferase following exposure of a GXXX(S/T/C) N-terminal consensus sequence. Although N-myristoylation has been historically described as a co-translational modification that occurs following the removal of the initiator Met residue of a protein, there are known examples of posttranslational N-myristoylation 15, 16 . In many instances, protein N-myristoylation is necessary but not sufficient to promote stable and permanent membrane association. Consequently, this modification often occurs together with S-palmitoylation of proximal Cys residues or with a polybasic amino acid domain next to the N terminus of the protein.
Pseudomonas syringae, which causes a range of diseases in plants, encodes many T3SS effectors that promote virulence in susceptible hosts or are recognized by host resistance proteins and thus trigger defence responses in resistant plants 17, 18 . A subset of these effectors, including avirulence protein B (AvrB), AvrRpm1, HopF2 and multiple members of the HopZ family, encode N-terminal eukaryotic consensus sites for N-myristoylation [19] [20] [21] . When expressed in susceptible plant cells, AvrB and AvrRpm1 are targeted to the plasma membrane 19 . Substitution of the crucial N-terminal Gly2 residue with an Ala in both proteins results in their mislocalization to the cytosol. In addition, both effectors are also S-palmitoylated on a Cys immediately following the Gly, and this modification increases effector association with the membrane 19 . Therefore, N-myristoylation and S-palmitoylation of these Avr effectors are required for correct plasma membrane localization. Both AvrB and AvrRpm1 have been shown to interact with and induce phosphorylation of RPM1-interacting protein 4
Box 1 | Type III and type IV secretion systems Many bacteria that are pathogens or symbionts of animals, plants or insects have evolved complex multiprotein machines known as type III and type IV secretion systems to deliver bacterial effector proteins into target eukaryotic cells 1, 2 . Proteins delivered by these machines possess specific targeting signals that selectively deliver the proteins to the transport machines. Inside the target cell, the various biochemical activities of these effector proteins can modulate a variety of eukaryotic host cell functions. Although these secretion machines have a common function, they clearly evolved independently, presumably from flagella in the case of the type III secretion system or from the bacterial conjugation systems in the case of the type IV secretion system. Both machines are composed of supramolecular structures that cross the entire bacterial envelope to provide a passageway for proteins travelling through this secretory pathway. It is believed that these machines must have evolved out of the need to deliver multiple proteins to the same target cell, presumably to modulate complex cellular processes in a manner in which a single biochemical activity might not be able to do. 31 showed that eight different Legionella effectors require the CaaX motif for membrane localization; one example is given here. ‡ Subcellular localization of multiple Pseudomonas syringae effectors, including Hop, Avr, Hol, and Hrp family members, was predicted by the program TargetP. Nature Reviews | Microbiology Consistent with the importance of these modifications for effector function, N-myristoylation and, to a lesser extent, S-palmitoylation were shown to be required for AvrB-and AvrRpm1-mediated triggering of defence responses in resistant plants and for the virulence phenotype of AvrRpm1 in susceptible hosts 19 . . c | Prenylation involves the covalent addition of a 15-carbon farnesyl or a 20-carbon geranylgeranyl isoprenoid group to a Cys residue within a conserved carboxy-terminal CaaX motif (in which a represents an aliphatic residue and X is one of four amino acids). When X is Ser, Met or Gln, the protein is recognized by a farnesyltransferase, and when X is Leu, the protein is modified by a geranylgeranyl transferase. The Legionella pneumophila effector ankyrin B (AnkB), which is secreted by the type IV secretion system, is essential for L. pneumophila proliferation within the Legionella-containing vacuole (LCV). Following AnkB translocation into the host cell, the C-terminal CaaX motif is farnesylated, allowing the effector to associate with the cytosolic face of the LCV. The S. enterica T3SS effector SifA is geranylgeranylated on a C-terminal CaaX motif. SifA is required for S. enterica pathogenesis and is thought to regulate membrane fusion as the Salmonella-containing vacuole (SCV) expands.
Caspases
A family of Cys-Asp proteases involved in apoptosis, necrosis and inflammasome activation.
Legionella-containing vacuole
A host cell membrane-dervived compartment in which intracellular growth of Legionella spp. occurs.
Salmonella-induced filaments
A tubular network of membranes that extend from the Salmonella-containing vacuole.
Both AvrB and AvrRpm1 possess conventional N-myristoylation sites like those found at the very N terminus of eukaryotic proteins, but another subset of Avr type III effectors, including AvrPphB (also known as HopAR1) and ORF4 from P. syringae, and nodulation protein NopT from Rhizobium spp., possesses internal N-myristoylation sites within their full-length protein sequences 24 . Interestingly, following translocation into host cells, these effectors undergo an autoproteolytic processing event that exposes a new N terminus which contains the N-myristoylation consensus sequence. This process is analogous to the N-myristoylation of certain eukaryotic proteins following cleavage by caspases to reveal cryptic N-myristoylation consensus sites 25 . The processed bacterial effectors are then N-myristoylated, as well as S-palmitoylated, by the host and targeted to the plasma membrane 24 . AvrPphB specifically cleaves the Arabidopsis thaliana plasma membrane-localized protein kinase PBS1 to inhibit the RPS5 (resistance to Pseudomonas syringae protein 5)-dependent immune response in susceptible hosts; in resistant plants, this PBS1 cleavage triggers defence responses 26, 27 . Dual lipidation is required not only for the plasma membrane localization of AvrPphB, but also for the activity of this effector 24 . Therefore, P. syringae encodes proteins bearing both conventional and cryptic eukaryotic N-myristoylation motifs that can functionally target bacterial effectors to the plasma membrane of the host cell during infection.
Prenylation. Prenylation is a permanent post-translational modification at the C terminus of a protein and is required for protein stability. This modification results in the localization of a protein to an intracellular membrane through attachment of the modified C terminus to the membrane. Prenylation involves the covalent addition of a 15-carbon farnesyl or a 20-carbon geranylgeranyl isoprenoid group to a Cys residue within the conserved C-terminal tetrapeptide CaaX motif (in which 'a' represents an aliphatic residue and X is one of four amino acids) 28 . The residue located at position X determines whether the protein will be farnesylated or geranylgeranylated: when X is Ser, Met or Gln, the protein is recognized by farnesyltransferases, and when X is Leu, the protein is modified by geranylgeranyltransferases 28 (FIG. 1c) . These prenyltransferases are found only in eukaryotic cells. Following prenylation, the terminal aaX sequence is cleaved off by RAS-converting enzyme 1 (RCE1), which is located in the ER membrane 29 . The C-terminal prenylated Cys residue is then methylated by isoprenyl-Cys carboxyl methyltransferases 30 . Legionella pneumophila, the cause of Legionnaires' disease, encodes several T4SS effectors with CaaX motifs within their sequences, and these CaaX motifs are required for subcellular localization of the T4SS effectors [31] [32] [33] . For example, following translocation into the host cytosol, the L. pneumophila effector ankyrin B (AnkB) is farnesylated on the Cys residue of a conserved CaaX motif by the host protein farnesyltransferase and, as a result, becomes associated with the cytosolic face of the Legionella-containing vacuole (LCV) 32 (FIG. 1c) .
Mutation of the crucial Cys residue to Ala or inhibition of host protein farnesyltransferase results in loss of farnesylation and failure to target to the LCV. The LCV membrane is derived from the ER, which contains the eukaryotic enzymes required for processing farnesylated proteins. It has therefore been proposed that immediately following translocation into the LCV, AnkB is locally prenylated, anchoring it into the LCV membrane 32 . AnkB also contains a eukaryotic F-box domain that is thought to recruit polyubiquitylated proteins to the LCV. AnkB is required for rapid acquisition of polyubiquitylated proteins and is essential for intracellular L. pneumophila proliferation. L. pneumophila strains expressing prenylation-deficient AnkB are unable to recruit polyubiquitylated proteins to the LCV and are attenuated in a mouse model of Legionnaires' disease 32, 33 . The S. enterica T3SS effector SifA contains a C-terminal non-traditional CaaX motif ( 331 CLCCFL) and is geranylgeranylated on Cys333 by a host geranylgeranyltransferase 34, 35 . SifA localizes to the Salmonellacontaining vacuole (SCV) (FIG. 1c) as well as to tubular membrane structures known as Salmonella-induced filaments (SIFs), which extend from the SCV during infection 36 . Inhibition of SifA prenylation leads to the mislocalization of SifA to the cytosol 34 . Although prenylation alone can facilitate interaction of the protein with cellular membranes, some prenylated proteins require either a stretch of basic amino acids or S-palmitoylation upstream of the prenylation site for their stable association with membranes. It was shown that Cys331 of SifA is S-palmitoylated, which presumably strengthens the association with membranes 34 . SifA is required for S. enterica pathogenesis and is thought to regulate membrane fusion to help provide sufficient membrane as the SCV expands 36 . Deletion of SifA results in a bacterial replication defect in macrophages and reduced bacterial colonization in mouse studies; however, prenylationand S-palmitoylation-deficient SifA strains do not show this phenotype 34 . Therefore, although targeting of SifA to the SCV and SIFs requires prenylation, the contribution of this localization to SifA function remains unclear.
Membrane targeting by ubiquitylation
Ubiquitylation results in the covalent attachment of ubiquitin to a Lys residue on a target protein and constitutes a common and important post-translational modification in eukaryotic cells 37 . Following the initial conjugation, a substrate can remain monoubiquitylated at a single Lys residue, or additional ubiquitin molecules can be ligated either to one of the seven Lys residues in the first ubiquitin molecule, resulting in polyubiquitylation, or to multiple Lys residues in the original protein, resulting in multiubiquitylation. The type of ubiquitylation and the topology of the ubiquitin chains that are formed direct the fate of the substrate 38 . Protein ubiquitylation can be a signal for proteasomedependent degradation of the protein, but it can also modulate protein function by, for example, changing protein localization or allowing the formation of multiprotein complexes [39] [40] [41] [42] [43] . Many bacterial effector proteins have evolved to directly modulate the ubiquityl ation Nature Reviews | Microbiology pathway by acting as deubiquitinases or E3 ligases, thus altering the function or stability of host target proteins 12, 44, 45 . Other effector proteins, however, use ubiquity lation to modulate their own function. For example, it has been shown that the half-life of some effectors is controlled by ubiquitin-mediated degradation 46, 47 . In other cases, ubiquitylation can be crucial for targeting the effector protein to its final destination. SopB is an S. enterica T3SS effector that is involved in at least three distinct phenotypes, all of which are strictly dependent on SopB phosphoinositide phosphatase activity. By stimulating the host RHOG exchange factor SGEF (SRC homology 3 domain-containing guanine nucleotide exchange factor), SopB mediates actin-dependent S. enterica internalization into non-phagocytic cells 48 (FIG. 2) . In addition, SopB is required for activation of the protein kinase AKT1 by still poorly understood mechanisms, and this promotes intracellular survival of the bacterium 49 (FIG. 2) . Last, SopB can modulate the phosphoinositide composition of the SCV, thus modulating the membrane trafficking of this compartment 50 (FIG. 2) .
This functional diversification correlates with the temporal regulation of SopB localization. Early during infection, SopB localizes to the plasma membrane, where it activates RHOG and AKT. Later, it localizes to the SCV, where it modulates the phosphoinositide composition of the SCV membrane. The differential localization of SopB is strictly dependent on mono ubiquitylation of the protein, as a SopB mutant that cannot be ubiquitylated remains at the plasma membrane 51, 52 . Although this mutant can mediate RHOG-dependent entry and AKT activation, it is unable to localize to the SCV, resulting in a defect in intracellular growth. The ubiquitin-mediated relocalization of SopB is reminiscent of the ubiquitin-mediated relocalization of epidermal growth factor receptor (EGFR) from the plasma membrane to an endocytic compartment in eukaryotes 53, 54 . However, although both proteins are relocalized in a ubiquitin-dependent manner, the cellular machinery necessary for this relocalization seems to be different for each protein, as depletion of proteins required for EGFR delivery to an endosomal compartment (that is, components of the ESCRT (endosomal sorting complex required for transport) complex) does not affect SopB delivery to the SCV 52 .
Membrane targeting by phospholipid binding
Phosphoinositides play an essential part in regulating a variety of cellular processes ranging from membrane trafficking to actin dynamics [55] [56] [57] . The reversible phosphorylation of the inositol group of phosphoinositides at different positions and in various combinations can generate seven phosphoinositide species, which concentrate in different intracellular membranes. This differential distribution is highly regulated and allows for effective subcellular targeting of host membraneassociated signalling events. Phosphoinositides serve as anchor moieties for a variety of proteins with binding domains that are selective for different phosphoinositide species. Many bacterial effectors have been shown to use phosphoinositides to accurately target their biochemical activities 58, 59 . For example, several L. pneumophila T4SS effectors are targeted to the LCV by binding different phosphoinositides: SidC and SidM (also known The Salmonella enterica phosphoinositide phosphatase SopB is secreted into the host cell by the type III secretion system. Temporal regulation of the SopB cellular localization leads to three distinct activities. Early during infection, SopB localizes to the plasma membrane, where it stimulates the RHOG exchange factor SGEF (SRC homology 3 domain-containing guanine nucleotide exchange factor), thus mediating actin-dependent S. enterica internalization into non-phagocytic cells. At the plasma membrane. SopB also promotes intracellular survival by activating the protein kinase AKT1. Later in infection, SopB is monoubiquitylated, and this modification facilitates SopB localization to the Salmonella-containing vacuole (SCV), where the effector modulates the phosphoinositide composition and charge distribution of the membrane, thus affecting the membrane trafficking of this compartment. Ub, ubiquitin.
Guanine nucleotide exchange factor (GEF). A protein that induces a GTPase to exchange GTP for GDP, resulting in activation of the GTPase.
as DrrA) are targeted by binding phosphatidylinositol-4-phosphate (PtdIns4P) [60] [61] [62] [63] , SetA by interacting with PtdIns3P 64 , and LidA by binding both of these phosphoinositides 62, 63 . Together, these effectors influence the remodelling and maturation of the LCV by promoting the interaction of the LCV with host vesicles and organelles. Interestingly, the discrete domains of these effectors that bind PtdIns4P or PtdIns3P do not exhibit any detectable sequence or structural similarity to equivalent domains in eukaryotic proteins, suggesting that these domains are the result of convergent evolution, a common theme in the evolution of effector proteins 65 . The Pseudomonas aeruginosa T3SS effector protein ExoU is another example of an effector that is targeted to its final destination by phosphoinositide binding. ExoU is a phospholipase that is targeted to the plasma membrane by a discrete α-helical bundle domain at its C terminus; this domain has a high affinity for PtdIns-4,5-bisphosphate (PtdIns(4,5)P 2 ), which is abundant at the cytoplasmic side of the plasma membrane 66, 67 .
Targeting of the ExoU phospholipase activity to the plasma membrane via the ExoU C-terminal phosphoinositide-binding domain leads to rapid necrotic host cell death by disrupting host cell membranes, and this promotes P. aeruginosa pathogenesis [67] [68] [69] . Helicobacter pylori infections are associated with the development of stomach cancer 70 . Central to the pathogenesis of this bacterium is the function of a T4SS that, through the delivery of the effector CagA, modulates a variety of host cell functions 71 . Following delivery by the T4SS, CagA localizes to the inner surface of the plasma membrane of polarized cells 72 . Targeting of CagA to this location involves binding to phosphatidylserine through a non-canonical PH (pleckstrin homology) domain. However, in nonpolarized cells, CagA is targeted to the plasma membrane by a C-terminally located EPIYA (Glu-Pro-Ile-Tyr-Ala) motif. It has been proposed that this targeting mechanism must involve an EPIYA motifbinding protein that interacts with CagA 73 , although such a protein has not yet been identified.
Targeting to mitochondria and chloroplasts
Eukaryotic cells use similar mechanisms to target proteins to mitochondria and chloroplasts. Most eukaryotic mitochondrial and chloroplast proteins are synthesized in the cytosol as pre-proteins that encode either an N-terminal pre-sequence or an internal targeting signal 74, 75 . The pre-sequence forms an amphiphilic α-helix with positively charged residues on one side of the helix and hydrophobic residues aligned on the other side. During synthesis, many mitochondrial and chloroplast pre-proteins associate with molecular chaperones that maintain them in a partially unfolded conformation before targeting to the organelle.
The targeting mechanisms for mitochondrial proteins have been examined in detail. The targeting signal is recognized by receptor subunits of the TOM (transport outer membrane) and TIM (transport inner membrane) complexes present in mitochondrial membranes. Following binding of the pre-sequence to these complexes, the pre-protein is imported across the mitochondrial membranes in an unfolded state. After translocation, the pre-sequence is usually cleaved off, and chaperones in the mitochondrial matrix mediate protein folding 76 . Mitochondrial import is generally described as a post-translational process, implying that proteins are completely synthesized before import starts 74 . Amino acid sequence analysis revealed that the N-terminal T3SS signals of most P. syringae effectors have a similar amino acid composition to chloroplast and mitochondrial targeting pre-sequences 77 . As a result, most P. syringae effectors are predicted to localize to chloroplasts or mitochondria 77 . However, this similarity could merely imply an evolutionarily conserved mechanism used by these organelles and the T3SS to recognize and target substrates. Therefore, caution should be exercised before assigning a mitochondrial or chloroplast localization to bacterial T3SS effectors on the basis of bioinformatic analysis alone. Nevertheless, studies have shown that, when transiently expressed in plants, the P. syringae effectors HopL1 and HopG1 are targeted to chloroplasts and mitochondria, respectively, altering thylakoid structures (in the case of HopL1) and suppressing host defences (in the case of both proteins) 78, 79 . The targeting of HopL1 and HopG1 seems to involve non-canonical mechanisms, as these particular effectors do not have canonical targeting signals and do not undergo proteolytic processing following targeting. Whether these effectors are targeted to chloroplasts or mitochondria during bacterial infection remains unknown.
In addition to P. syringae effectors, the enteropathogenic Escherichia coli (EPEC) T3SS effectors Map, EspF and EspZ encode putative N-terminal mitochondrial pre-sequences with cleavage signals 80, 81 . After Map delivery into the host cell by the T3SS, the N terminus of the protein can be cleaved, and Map then localizes to host mitochondria, indicating that the host cell mitochondrial targeting machinery can recognize Map as a substrate 80 . In vitro assays showed that mitochondrial import of Map involves components of the mitochondrial import pathway (TOM22, TOM40 and mtHSP70 (also known as GRP75)), which is consistent with Map import into the mitochondria matrix via the classical import mechanism 82 (FIG. 3) . In addition, it has been reported that Map disrupts the mitochondrial membrane potential, leading to mitochondrial fragmentation 80, 82 . More recent structural and functional studies, however, have shown that EPEC Map is a guanine nucleotide exchange factor (GEF) 83, 84 . In addition to a GEF domain, Map possesses a canonical C-terminal PDZ-binding motif that interacts with the PDZ domains of ezrinradixin-moesin-binding phosphoprotein 50 (EBP50; also known as NHERF1) 85, 86 . Following translocation, Map localizes to the plasma membrane at the bacterium-host interface 86 . This localization results in cell division cycle 42 (CDC42) activation, leading to the localized formation of actin-rich membrane protrusions 86 (FIG. 3) . Although this particular activity seems to be at odds with the reported mitochondrial localization of Map, and the mitochondrial membrane disruption Nature Reviews | Microbiology caused by the protein, it has been observed that at later time points, Map colocalizes with the mitochondria. It is therefore possible that Map has a dual function, working as a GEF for CDC42 to mediate actin rearrangements at the plasma membrane early during infection, thus promoting bacterial attachment, and disrupting mitochondrial function later in infection.
Some studies have suggested that the EPEC T3SS effector EspF is targeted to host mitochondria 81, 85, [87] [88] [89] (FIG. 3) . However, other studies have also observed that EspF can be targeted to the nucleus and/or plasma membrane 87, 88 . Some of these disparate subcellular localizations could be a result of the use of epitope tags or, in some instances, overexpression to visualize the protein, as these factors can alter the physiological localization of proteins. Alternatively, the disparate locations for EspF could be a reflection of functional diversification, as several functions have been attributed to this effector, including disruption of tight junctions, inhibition of phagocytosis, remodelling of the plasma membrane, rearrangement of the cytoskeleton, disruption of the nucleolus, disruption of mitochondrial function, and apoptosis 90, 91 . Finally, it should be observed that when ectopically expressed within mammalian cells, some bacterial proteins can localize to the host mitochondria despite clear evidence that during infection this is not their final destination 92 , suggesting that cryptic mitochondrial targeting signals are common in bacterial proteins. Therefore, the observation that an effector protein targets to mitochondria should be interpreted with caution in the absence of functional evidence to support the physiological relevance of such an observation.
Nuclear localization
Given the central importance of nuclear functions in cellular physiology, it is not surprising that many bacterial effectors have evolved to carry out their function within the nucleus of an infected cell [93] [94] [95] [96] [97] [98] [99] [100] . Most proteins that function in the nucleus are selectively imported from the cytosol through nuclear pore complexes, which are large structures that form channels allowing proteins smaller than the diameter of the channel to passively diffuse into the nucleus. Globular proteins larger than 50 kDa are unable to passively diffuse through the nuclear pore complex and therefore require active import, which is dependent on the presence of a nuclear localization signal (NLS) in the protein.
Several pathways for nuclear import have been described. The classical NLS consists of either one (monopartite) or two (bipartite) short amino acid sequences rich in the positively charged amino acids Lys and Arg. NLSs can be present in multiple copies, usually forming a loop on the surface of the fully folded protein. NLSs are recognized by soluble carriers of the importin-α and importin-β superfamilies 101 . In classical nuclear import, importin-α recognizes and binds both the nuclear cargo and importin-β in the cytoplasm, and importin-β then mediates the interaction of the complex with the nuclear pore as it translocates into the nucleus [102] [103] [104] . When the complex reaches the nucleus, RAN·GTP binds to importin-β, causing a conformational change that results in the release of the importin-α-cargo complex into the nucleus 105 . In most instances, the transport of bacterial effector proteins into the nucleus is carried out by the cellular nuclear import machinery. For example, members of the plant pathogen genus Xanthomonas encode a large family of transcription activator-like (TAL) T3SS effectors, including AvrBs3, AvrXa5, AvrXa7, AvrXa10 and PthA, which localize to the plant nucleus and regulate plant gene expression during infection 94 . TAL effectors are characterized by a central DNA-binding region consisting of a nearly identical tandem of 34 amino acid repeats, followed by a classic monopartite NLS and an acidic transcriptional activation domain (AAD) 94, 95 . In susceptible host species, the TAL effector AvrBs3 of Xanthomonas campestris pv. vesicatoria modulates gene expression to induce hypertrophy of plant host cells 106 . By contrast, in resistant species, AvrBs3 triggers defence responses, leading to localized host cell death. Both responses require the NLS and AAD of AvrBs3, supporting a functional role for AvrBs3 in the host nucleus [106] [107] [108] . Sequence analysis revealed three putative NLSs within T-DNA Nucleus the C-terminal domain of AvrBs3 and found that these sequences are conserved in other members of the TAL family 109 . NLS2 and NLS3 of AvrBs3 were shown to be required for AvrBs3 to be fully active, whereas NLS1 is insufficient for AvrBs3 activity 107, 110 . In Capsicum annuum plants expressing the Bs3 protein, AvrBs3 was shown, by both yeast two-hybrid and in vitro binding assays, to interact with the importin-α proteins CALMPα1 and CALMPα2, two members of the classical nuclear import pathway that mediate nuclear import by binding the NLS of a substrate protein in the cytosol 110 . The interaction of AvrBs3 with CALMPα1 and CALMPα2 was shown to be dependent on NLS2 (REF. 110 ). Therefore, following translocation into the host cell cytosol, AvrBs3 is targeted to the nucleus by the classical eukaryotic nuclear import pathway, and there it alters host gene expression.
Agrobacterium tumefaciens pathogenesis requires the transfer of bacterial tumour-inducing DNA (transfer DNA (T-DNA)) into the host plant cell 111 . The T-DNA is then imported into the cell nucleus and integrates into the plant cell genome. Expression of T-DNA-encoded genes leads to tumour formation in the host plant. The nuclear import of T-DNA requires the function of two A. tumefaciens T4SS effectors, VirD2 and VirE2 (FIG. 4) . VirD2 associates with the 5′ end of the single-stranded T-DNA, and VirE2 coats the rest of the T-DNA molecule 112, 113 . Both VirD2 and VirE2 possess functional NLSs. Of the two NLSs in VirD2, the C terminus-proximal NLS has been shown to target reporter proteins to the nucleus in plant, animal and yeast cells 96, 97 . VirD2 binds the A. thaliana importin-α subunit KAPα1 in a manner dependent on the presence of the C terminus-proximal NLS 114 , consistent with KAPα1 acting as an import receptor for the classical nuclear import pathway.
Concluding remarks
Some bacteria have evolved simple mechanisms to deliver a limited number of biochemical activities into eukaryotic cells in the form of exotoxins. The delivery mechanisms are so simple that all the necessary information is contained within a single polypeptide in some instances and in just a handful of proteins in the more complex cases. However, the need to deliver multiple (in some cases, more than 100) biochemical activities into the same cell in the form of effector proteins and in a temporally and spatially restricted manner has demanded the evolution of the T3SS and T4SS, which are much more complex delivery machines. The diversity of the biochemical activities of these effectors and the coordination that is necessary for them to exert their appropriate functions demand that the effectors are targeted precisely to the appropriate subcellular location. It is becoming increasingly clear that this requires host cell machinery which is usurped by these effectors to reach their final destination. The challenge for the future will be to visualize the fate of the translocated effectors in live cells during bacterial infection. This is difficult because, in addition to the intrinsic limitations of the protein delivery systems themselves, the effector proteins are delivered at very low concentrations. Therefore, more sensitive live-imaging techniques will be required to address this important issue. It is also evident that in order to understand the contribution of the different effectors to bacterial pathogenesis, we need a better understanding of their subcellular localizations following translocation. It is also possible that information gained by studying the targeting mechanisms used by different effectors will lead to the development of novel therapeutic strategies to combat infections by these pathogens. Agrobacterium tumefaciens must transfer the bacterial tumour-inducing DNA (known as transfer DNA (T-DNA)) into the host plant cell, where it is imported into the nucleus and integrates into the plant cell genome. The nuclear import of T-DNA requires two A. tumefaciens effectors, VirD2 and VirE2, which are secreted into the host cell via the type IV secretion system. VirD2 associates with the 5′ end of the single-stranded T-DNA, and VirE2 coats the rest of the T-DNA. Both effectors contain nuclear localization signals (NLSs). VirD2 has been shown to bind the A. thaliana importin-α subunit KAPα1 in an NLS-dependent manner, suggesting that KAPα1 is an import receptor for the classical nuclear import pathway.
